Bliss GVS Pharma Limited — Updates, 12-05-2026: General Updates

Bliss GVS Pharma proposed a final dividend of Re 1 per share. The company sold its 51% stake in a Nigerian subsidiary for $1.3 million (approx 10.79 Cr) and established new subsidiaries in Kenya and Congo, indicating strategic expansion. Consolidated net profit for the year was 90.31 Cr.